Taylor VL - Search Results

1

Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.

Kehne JH, McCloskey TC, Taylor VL, Black CK, Fadayel GM, Schmidt CJ. Kehne JH, et al. Among authors: taylor vl. J Pharmacol Exp Ther. 1992 Jan;260(1):78-89. J Pharmacol Exp Ther. 1992. PMID: 1731054

2

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.

Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL. Schmidt CJ, et al. Among authors: taylor vl. Eur J Pharmacol. 1992 Nov 13;223(1):65-74. doi: 10.1016/0014-2999(92)90819-p. Eur J Pharmacol. 1992. PMID: 1362159

3

The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.

Schmidt CJ, Black CK, Taylor VL, Fadayel GM, Humphreys TM, Nieduzak TR, Sorensen SM. Schmidt CJ, et al. Among authors: taylor vl. Eur J Pharmacol. 1992 Sep 22;220(2-3):151-9. doi: 10.1016/0014-2999(92)90743-n. Eur J Pharmacol. 1992. PMID: 1425989

4

5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.

Sorensen SM, Humphreys TM, Taylor VL, Schmidt CJ. Sorensen SM, et al. Among authors: taylor vl. J Pharmacol Exp Ther. 1992 Feb;260(2):872-8. J Pharmacol Exp Ther. 1992. PMID: 1531362

5

L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.

Schmidt CJ, Black CK, Taylor VL. Schmidt CJ, et al. Among authors: taylor vl. Eur J Pharmacol. 1991 Oct 2;203(1):41-9. doi: 10.1016/0014-2999(91)90788-r. Eur J Pharmacol. 1991. PMID: 1686766

6

5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.

Schmidt CJ, Taylor VL, Abbate GM, Nieduzak TR. Schmidt CJ, et al. Among authors: taylor vl. J Pharmacol Exp Ther. 1991 Jan;256(1):230-5. J Pharmacol Exp Ther. 1991. PMID: 1899117

7

Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors.

Schmidt CJ, Taylor VL. Schmidt CJ, et al. Among authors: taylor vl. Eur J Pharmacol. 1990 May 31;181(1-2):133-6. doi: 10.1016/0014-2999(90)90254-4. Eur J Pharmacol. 1990. PMID: 1974853

8

Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.

Schmidt CJ, Black CK, Taylor VL. Schmidt CJ, et al. Among authors: taylor vl. Eur J Pharmacol. 1990 May 31;181(1-2):59-70. doi: 10.1016/0014-2999(90)90245-2. Eur J Pharmacol. 1990. PMID: 1974858

9

Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.

Schmidt CJ, Abbate GM, Black CK, Taylor VL. Schmidt CJ, et al. Among authors: taylor vl. J Pharmacol Exp Ther. 1990 Nov;255(2):478-83. J Pharmacol Exp Ther. 1990. PMID: 1978728

10

Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.

Schmidt CJ, Black CK, Abbate GM, Taylor VL. Schmidt CJ, et al. Among authors: taylor vl. Brain Res. 1990 Oct 8;529(1-2):85-90. doi: 10.1016/0006-8993(90)90813-q. Brain Res. 1990. PMID: 1980848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters